Nuveen’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-22,600
Closed -$6K – 3285
2022
Q1
$6K Buy
+22,600
New +$5.31M ﹤0.01% 3307
2021
Q2
– Sell
-25,800
Closed -$5K – 3396
2021
Q1
$5K Buy
+25,800
New +$5.08M ﹤0.01% 3325
2020
Q2
– Sell
-15,300
Closed -$3K – 3287
2020
Q1
$3K Buy
+15,300
New +$3.05M ﹤0.01% 3172

Other funds holding CME

Nuveen's CME Position: Q3 2026 in Review

Nuveen reduced its CME Group (CME) stake by 0.28% in Q3 2026, selling an estimated $672K and leaving 923,433 shares worth $242M. The position accounts for 0.06% of the portfolio, ranked #237.

Nuveen first reported a position in CME in Q2 2013 and has held it in 54 quarters since. The position peaked at $663M in Q3 2019. 1,099 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Nuveen held 923,433 shares of CME Group worth $242M as of Q3 2026.
  • Nuveen sold 2,549 CME Group shares in Q3 2026, an estimated $672K.
  • CME Group made up 0.06% of Nuveen's portfolio in Q3 2026, its #237 holding.
  • Nuveen first reported a position in CME Group in Q2 2013 and has held it in 54 quarters since.
  • Nuveen's CME Group position peaked at $663M in Q3 2019.
  • 1,099 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.